Zhang AI-OCT (DME)
2026
An AI-Based OCT System to Detect Diabetic Macular Edema: A Prospective Validation and Noninferiority Randomized Clinical Trial
In 276 patients referred with suspected diabetic macular oedema, an AI-based OCT report added to the referral decision reduced false-positive referrals compared with referral on the fundus-photograph screening report alone.
Result
- Absolute difference
- 45.0 points
- NNT
- 3
absolute difference-45.095% CI -58.2 to -31.9 · P < 0.001
Absolute difference and NNT are derived from the event rates.
Also reported: For non-inferiority). Sensitivity for DME referral 100.0% in both groups; specificity 86.5% vs 0.0%. Silent-mode validation (603 patients): sensitivity 98.8%, specificity 90.7%.
- Subtopic
- Prioritisation & triage
- Design
- Prospective silent-mode validation + multicentre non-inferiority RCT, Hong Kong
- Relevance
- Important: one of several pillars.
- Source
- Zhang S, et al. JAMA. 2026;336(3):215-223.doi 10.1001/jama.2026.7025
Discussion & critique
A model of stepwise evaluation: silent-mode validation first, then a randomised trial, showing that an AI-OCT second-stage screen can cut unnecessary specialist referrals for DME substantially without missing a case. The trial is small, drawn from a single screening programme, and because every participant was ultimately seen by a specialist it measures referral accuracy rather than downstream visual outcomes.